Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.350
+0.050 (3.85%)
At close: Sep 14, 2026, 4:00 PM EDT
1.340
-0.010 (-0.74%)
After-hours: Sep 14, 2026, 7:48 PM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $39.01M in the quarter ending June 30, 2026, a decrease of -1.91%. This brings the company's revenue in the last twelve months to $159.27M, up 2.02% year-over-year. In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth.

Revenue (ttm)
$159.27M
Revenue Growth
+2.02%
P/S Ratio
2.63
Revenue / Employee
$328,394
Employees
485
Market Cap
419.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025160.01M5.99M3.89%
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 201878.63M-14.84M-15.88%
Dec 31, 201793.47M2.75M3.04%
Dec 31, 201690.71M-2.07M-2.23%
Dec 31, 201592.78M32.19M53.12%
Dec 31, 201460.59M32.41M115.02%
Dec 31, 201328.18M2.20M8.46%
Dec 31, 201225.98M-7.88M-23.27%
Dec 31, 201133.86M32.19M1,922.88%
Dec 31, 20101.67M1.54M1,140.00%
Dec 31, 2009135.00K-766.00K-85.02%
Dec 31, 2008901.00K-1.26M-58.34%
Dec 31, 20072.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Orthofix Medical833.19M
Viemed Healthcare301.61M
Cerus221.55M
NeuroPace106.99M
Sight Sciences83.38M
908 Devices60.84M
Shoulder Innovations60.06M
Senseonics Holdings48.55M
Revenue Rankings